Article Details

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com UK

Retrieved on: 2024-10-23 15:54:24

Tags for this article:

Click the tags to see associated articles and topics

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com UK. View article details on hiswai:

Excerpt

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT), a pharmaceutical company, has received an extension from the Nasdaq Stock Market to meet the ...

Article found on: uk.investing.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up